Phenotypic Susceptibilities to Tenofovir in a Large Panel of Clinically Derived Human Immunodeficiency Virus Type 1 Isolates

Tenofovir is a nucleotide analogue human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) inhibitor, and its oral prodrug, tenofovir disoproxil fumarate, has recently been approved for the treatment of HIV-1 infection in the United States. The objective of this study was to character...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Harrigan, P. R., Miller, M. D., McKenna, P., Brumme, Z. L., Larder, B. A.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2002
Témata:
Antiviral Agents
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC127100/
https://ncbi.nlm.nih.gov/pubmed/11897591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.4.1067-1072.2002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky